Literature DB >> 6112440

Rapid desensitisation for desferrioxamine anaphylactic reaction.

K B Miller, L J Rosenwasser, J A Bessette, D J Beer, R E Rocklin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6112440     DOI： 10.1016/s0140-6736(81)92227-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Deferoxamine (desferrioxamine). New toxicities for an old drug.

Authors:  Y Bentur; M McGuigan; G Koren
Journal:  Drug Saf       Date:  1991 Jan-Feb       Impact factor: 5.606

2.  High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.

Authors:  H Breithaupt; H Heckers; H Pralle; W Guttmann; H Bleyl; V Graef; G Jundt
Journal:  Blut       Date:  1986-04

3.  Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA.

Authors:  B Wonke; A V Hoffbrand; M Aldouri; D Wickens; D Flynn; M Stearns; P Warner
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

Review 4.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 5.  A risk-benefit assessment of iron-chelation therapy.

Authors:  J B Porter
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.228
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.